The award is the first following a funding announcement last year to support typhoid fever diagnostic test development.
The firm saw a 8 decline in diagnostics revenue and projected a more pronounced decline in fiscal Q2, due primarily to volume-based pricing headwinds.
The survey of 152 clinicians also found that turnaround time and payor coverage are among the most important considerations for doctors when ordering cancer testing.